Earnings Review · 22 October 2026
The print
Revenue $20.06B.
EPS $7.97 vs $7.52 expected.
What changed versus going in
Earnings came in at $7.97 a share against $7.52 expected, a beat of 6% (+$0.45 a share). Revenue of $20.06B compares with $20.50B expected, 2.1% below consensus.
Did the flow confirm the move?
Underlying money flow reads as accumulation (21-day Chaikin Money Flow +0.06, five-day price change +5.6%, as of 2026-10-21, desk flow model).
Give the business its due
The business itself is genuinely strong: revenue growing about 10%,
net margins near 8%, a narrow competitive moat, backed by a 89%
return on equity.
Levels that matter
At $551.51 the shares sit 20% below the 52-week high of $692.00 and 26% above the low of $437.25 (45% of the way up the range). The 50-day average is $543.16, below the price. The 200-day average is $554.73, above the price.
The valuation lens
The shares trade about 15% below our fair-value estimate: a modest cushion. Fair value lands near $614 against a $532.64 share price, a margin of safety of about 15%. The trailing multiple sits around 19 times earnings, which only makes sense if the growth holds.
The
ethical lens, our differentiator
Fails the principled screen, Business activity screen. A strong business is not the same as a suitable one; for a values-conscious book this is a do-not-chase regardless of the print.
The compliant alternative
There is no direct compliant equivalent in the same industry on our screen, the honest answer is to screen a step wider rather than reach for a false substitute.
The verdict for a values-conscious investor
A beat-and-raise does not change the screen. This is a great company you can admire without owning, protection first. One quarter, strong or soft, does not decide whether a holding is suitable.
This is analysis, not financial advice. Always manage your risk.